Likewise, it has been shown that deletion of the ETS translocation variant 4 (ETV4), a candidate factor controlling ER genomic binding in endometrial cancer cells, led to decreased growth in 3D cultures of the Ishikawa endometrial cancer cell line (72). Here, ETV4 is linked to endometrial cancer.